REQUEST A DEMO
Total
USD $0.00
Search more companies

Magadanskie Apteki OOO (Магаданские Аптеки ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Magadanskie Apteki OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Magadanskie Apteki OOO (Магаданские Аптеки ООО) is an enterprise in Russia, with the main office in Magadan. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on February 06, 2020. In its most recent financial highlights, the company reported a net sales revenue drop of 16.35% in 2024. Its’ total assets recorded a negative growth of 8.24%. The net profit margin of Magadanskie Apteki OOO (Магаданские Аптеки ООО) increased by 0.97% in 2024.

Headquarters
Bilibina, 5
Magadan; Magadan Oblast; Postal Code: 685000

Contact Details: Purchase the Magadanskie Apteki OOO (Магаданские Аптеки ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the Magadanskie Apteki OOO (Магаданские Аптеки ООО) report to view the information.
Incorporation Date:
February 06, 2020
Company Performance
Financial values in the chart are available after Magadanskie Apteki OOO (Магаданские Аптеки ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-16.35%
Total operating revenue
-16.35%
Operating profit (EBIT)
42.35%
Net Profit (Loss) for the Period
26.66%
Total Assets
-8.24%
Total Equity
-20.37%
Operating Profit Margin (ROS)
1.73%
Net Profit Margin
0.97%
Return on Equity (ROE)
-10.85%
Debt/Equity
22.69%
Quick Ratio
0.03%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?